U.S. stocks slipped in light trading on Thursday ahead of the holiday season, pulling the Dow Jones Industrial Average further away from 20,000, a level it has never breached.
The Dow Jones Industrial Average was down 0.22 percent at 19,898.93, the S&P 500 was down 0.33 percent at 2,257.6 and the Nasdaq Composite was down 0.61 percent at 5,438.038.
** MICRON TECHNOLOGY INC, $22.96, +11.56 pct
The chipmaker forecast current-quarter revenue and profit above estimates as a stabilizing PC market spurs demand and boosts prices of its memory chips.
** RED HAT INC, $69.98, -12.29 pct
The Linux OS distributor reported lower-than-expected quarterly revenue, prompting at least two brokerages to downgrade the stock.
** OVASCIENCE INC, $1.415, -52.36 pct
The fertility treatment provider said it would slow commercial expansion of its fertility treatment Augment, citing insufficient near-term financial return.
** APPLE INC, $115.92, -0.97 pct
Nokia Corp said on Wednesday it had filed a number of lawsuits against the iPhone maker for violating 32 technology patents, striking back at the iPhone maker’s legal action targeting the one-time cellphone industry leader a day earlier.
** WEIGHT WATCHERS INTERNATIONAL INC, $11.72, +11.41 pct
The weight management company introduced new advertising campaign in the U.S. featuring Oprah Winfrey. Two new TV ads will air on Dec 26.
** IRONWOOD PHARMACEUTICALS INC, $15.165, -5.28 pct
The company with partner Allergan announced mid-stage data involving two versions of their linaclotide drug, which is approved to treat irritable bowel syndrome with constipation.
** FLOTEK INDUSTRIES INC, $9.69, +3.64 pct
The company said MHA Petroleum Consultants confirmed in a letter that there was a significant increase in oil recovery per foot when it used a Flotek additive.
** CATABASIS PHARMACEUTICALS INC, $3.9172, +9.11 pct
H.C. Wainwright began coverage of the stock with a “buy” rating and a $14 price target.
** AAR CORP, $34.08, -9.27 pct
The aircraft maintenance providers’ quarterly revenue slipped 1.78 percent due to lower sales at its aviation services division.
** IMPRIMIS PHARMACEUTICALS INC, $2.32, +15.42 pct
The company and FocusScript LLC launched Correct Compound program, which combines low-cost alternative compounded medications with a billing and claims management platform.
** CONAGRA BRANDS INC, $39.2, +3.16 pct
The maker of Chef Boyardee pasta and Orville Redenbacher’s popcorn reported a better-than-expected quarterly profit, helped by less discounting and lower costs.
** PRIMA BIOMED LTD, $0.7325, +4.33 pct
The Australian biotech company said its breast cancer drug succeeded in a mid-stage trial.
** SECOND SIGHT MEDICAL PRODUCTS INC, $2.185, +12.63 pct
The eye drug maker said UK’s National Health Service system would fund treatment of retinitis pigmentosa, a chronic hereditary eye disease characterized by black pigmentation and gradual degeneration of the retina, with Argus II bionic eye.
** CEMTREX INC, $5.57, +15.80 pct
The air filtration equipment maker reported a 65 percent jump in fiscal 2016 revenue, boosted by acquisitions.
** CALAMP CORP, $14.57, -7.37 pct
The wireless device maker reported lower-than-expected quarterly revenue as two large international orders were delayed.
** TRINET GROUP, $26.11, +2.59 pct
Private company Atairos Group Inc said it would buy a stake of about 26 percent in human resources services provider Trinet from investment firm General Atlantic LLC, becoming the largest shareholder.
** HARVEST NATURAL RESOURCES INC, $6.12, +4.97 pct
The oil and gas producer said it would sell all of its oil and gas assets in Gabon for $32 million to Singapore-based private company BW Energy Gabon.
** TOKAI PHARMACEUTICALS INC, $1.39, +37.62 pct
Tokai and privately held Otic Pharma Ltd announced that the two companies, together with Otic Pharma shareholders, entered into a definitive share purchase deal under which Otic Pharma shareholders would become majority owners of Tokai.
** HERMAN MILLER INC, $34.375, -3.17 pct
The furniture maker reported quarterly sales below analysts’ estimate on Wednesday, citing lower-than-expected orders.
** BED BATH & BEYOND INC, $41.675, -8.53 pct
The home furnishing retailer reported third-quarter profit well below analysts’ estimate, hurt by higher costs.
** RENREN INC, $1.68, +1.82 pct
Chinese social networking company said it formed a special committee to review the terms of a proposed spin-off of its new subsidiary.
** XOMA CORP, $5.5701, +1.27 pct
The drug developer entered into two royalty interest acquisition agreements with Healthcare Royalty Partners II.
** AURINIA PHARMACEUTICALS INC, $2.135, -21.51 pct
The Canadian drug developer announced a sale of 11.1 million shares in a $25 million bought deal financing. (Compiled by Sruthi Shankar in Bengaluru)